Genentech · 2 hours ago
2026 Summer Intern - Data Science Acceleration
Genentech is a leading biotechnology company focused on innovation and healthcare access. They are seeking a Data Science Intern to develop scalable tools and workflows for statistical computing in Product Development Data Sciences, collaborating with experts to streamline evidence generation and decision-making processes.
BiotechnologyLife ScienceManufacturing
Responsibilities
Develop experience in statistical analysis of clinical trial data
Develop AI agents to address specific business problems
Learn about the role of data sciences in drug development
Qualification
Required
Must be pursuing a Master's Degree (enrolled student)
Must have attained a Master's Degree
Must be pursuing a PhD (enrolled student)
Must have attained a PhD
Required Majors: Computer Science, Data Science, Statistics, BioInformatics, Engineering or a related quantitative discipline
Proficient in programming languages commonly used in statistical computing (e.g., R, Python) and are familiar with development tools such as Git, Docker, or workflow automation tools
Solid understanding of clinical trial data structures, statistical analysis concepts, or biomedical data (e.g., omics, real-world data, operational data)
Preferred
Excellent communication, collaboration, and interpersonal skills
Complements our culture and the standards that guide our daily behavior & decisions: Integrity, Courage, and Passion
Benefits
Paid holiday time off benefits
Company
Genentech
Genentech is a biotechnology research company that specializes in genetic testing and personalized medicines.
H1B Sponsorship
Genentech has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (167)
2024 (148)
2023 (150)
2022 (178)
2021 (121)
2020 (158)
Funding
Current Stage
Public CompanyTotal Funding
unknown2009-03-26Acquired
1999-07-20IPO
1976-01-01Series Unknown
Leadership Team
Recent News
2026-01-23
Genetic Engineering News
2026-01-23
Company data provided by crunchbase